GUETH ANTON 4
4 · ANTARES PHARMA, INC. · Filed Jun 15, 2020
Insider Transaction Report
Form 4
GUETH ANTON
Director
Transactions
- Award
Common Stock
2020-06-11$2.73/sh+30,220$82,501→ 429,456 total - Award
Stock Option (right to buy)
2020-06-11+58,246→ 58,246 totalExercise: $2.73Exp: 2030-06-11→ Common Stock (58,246 underlying)
Footnotes (3)
- [F1]Represents grant of restricted stock units made under the Antares Pharma, Inc. Equity Compensation Plan. The shares vest one year from the grant date. The reporting person has elected to defer the receipt of shares until separation of service as a Director.
- [F2]Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. Equity Compensation Plan.
- [F3]The options vest and become exercisable one year from the grant date.